Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Vaccination against cutaneous leishmaniasis: Current status
P. C. Melby
Research output
:
Contribution to journal
›
Review article
›
peer-review
33
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Vaccination against cutaneous leishmaniasis: Current status'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Vaccination
100%
Cutaneous Leishmaniasis
100%
Sustained Expression
50%
Immune Response
25%
Protective Immunity
25%
Etiology
25%
Epidemiology
25%
Leishmania
25%
Recombinant
25%
Macrophages
25%
Soluble Leishmania Antigen
25%
Vaccine Candidate
25%
Subunit Vaccine
25%
Memory T Cells
25%
Effector Function
25%
Specific Memory
25%
Interleukin-12 (IL-12)
25%
Vaccine Adjuvant
25%
Disease Prevention
25%
T Cell Subpopulations
25%
Infected Macrophages
25%
Antigen-specific
25%
Interferon-α (IFN-α)
25%
Immune Stimulation
25%
Sand Fly Vectors
25%
Cutaneous Infection
25%
Intracellular Infection
25%
Vaccine-induced Immunity
25%
Antigenic Epitope
25%
Adverse Events
25%
Subclinical Infection
25%
Recombinant Antigen
25%
Geographical Distribution
25%
Recall Response
25%
Intracellular Parasites
25%
Antigenic Stimulation
25%
Skin Ulcer
25%
Prophylactic Vaccination
25%
Parasite Vaccines
25%
Killed Parasites
25%
Attenuated Parasite
25%
Sterile Immunity
25%
Severe Course
25%
Durable Immunity
25%
Effector T Cell Response
25%
Whole Parasite Vaccines
25%
Subversive
25%
Broad-based
25%
Purified Antigen
25%
Parasite Antigen
25%
Cutaneous Leishmaniases
25%
Immunology and Microbiology
Cutaneous Leishmaniasis
100%
Parasite
100%
Infectious Disease
42%
Infection
42%
Leishmania
28%
Macrophage
28%
Stable Expression
28%
T Cell
14%
Immune Response
14%
Parasite Antigen
14%
interferon
14%
Subunit Vaccine
14%
Antigen Specificity
14%
Memory T Cell
14%
Cell Population
14%
Geographic Distribution
14%
Intracellular Parasite
14%
Vaccine Adjuvant
14%
Epitope
14%
Antigen
14%
Phlebotominae
14%
Recombinant Antigen
14%
Immunostimulation
14%
Interleukin 12
14%
Cohort Effect
14%
Epidemiology
14%
Antigenic Stimulation
14%